SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-04-000288
Filing Date
2004-01-07
Accepted
2004-01-07 12:05:53
Documents
2
Period of Report
2003-11-30

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1416
3 EX-24 ex-24.htm EX-24 9026
  Complete submission text file 0001104659-04-000288.txt   12334
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Issuer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139
Business Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139 6173490200
VILLA KOMAROFF LYDIA (Reporting) CIK: 0001274224 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21481 | Film No.: 04512357